Company: MDCXW
Filing Date: 2025-05-27
Form Type: S-1
Source: 0001062993-25-010333
Chunk: 211

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-27
Form: S-1
Chunk 211
---
 this prospectus is a part completely. The SEC maintains an internet site at www.sec.gov, from which you can electronically access the registration statement and its exhibits.

<div align='center'>- 141 -

INDEX TO FINANCIAL STATEMENTS</div>

| Audited Financial Statements of Medicus Pharma Ltd. for the years ended December 31, 2024 and 2023     | Page |
|:-------------------------------------------------------------------------------------------------------|:-----|
| Report of Independent Registered Public Accounting Firm (PCAOB ID #274)                                | F-3  |
| Report of Independent Registered Public Accounting Firm (PCAOB ID #1930)                               | F-4  |
| Consolidated Financial Statements                                                                      | F-5  |
| Consolidated Balance Sheets                                                                            | F-6  |
| Consolidated Statements of Operations and Comprehensive Loss                                           | F-7  |
| Consolidated Statements of Changes in Shareholders' Equity                                             | F-8  |
| Consolidated Statements of Cash Flows                                                                  | F-9  |
| Interim Financial Statements of Medicus Pharma Ltd. for the three months ended March 31, 2025 and 2024 |      |
| Condensed Consolidated Balance Sheets                                                                  | F-25 |
| Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)                     | F-26 |
| Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited)                       | F-27 |
| Condensed Consolidated Statements of Cash Flows (Unaudited)                                            | F-28 |

<div align='center'>F-1</div>

Medicus Pharma Ltd.
Consolidated Financial Statements

For the years ended December 31, 2024 and 2023
(expressed in United States dollars, except number of shares)

<div align='center'>F-2</div>

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Shareholders of
Medicus Pharma Ltd. Opinion on the Financial Statements We have audited the accompanying consolidated balance sheet of Medicus Pharma Ltd. and Subsidiaries (the “Company”) as of December 31, 2024, and the related consolidated statements of operations and comprehensive loss, shareholders’ equity, and cash flows for the year then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December